Suppr超能文献

一种用于治疗视神经鞘膜瘤的新型自动非共面容积调强弧形治疗技术的剂量学评估

Dosimetric evaluation of a novel automated noncoplanar volumetric modulated arc therapy technique for treating optic nerve sheath meningiomas.

作者信息

Xiong Zhenyu, Cheng Chingyun, Zhou Lili, Eckroate Brett, Bell Loren, Warburton Fredrick, Huang David, Motwani Sabin B, Cathcart Charles S, Nie Ke, Yue Ning, Zhang Yin

机构信息

Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.

Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.

出版信息

Front Oncol. 2025 Jun 27;15:1531918. doi: 10.3389/fonc.2025.1531918. eCollection 2025.

Abstract

PURPOSE

This study aimed to evaluate the dosimetric outcomes for the target and organs at risk (OARs) in patients with optic nerve sheath meningiomas (ONSMs), comparing HyperArc (HA), a novel automated noncoplanar volumetric modulated arc therapy (VMAT) technique, with two other advanced VMAT techniques.

METHODS

Nine patients with ONSMs were re-planned using three radiotherapy techniques: HA employing four preconfigured noncoplanar partial arcs on the Varian TrueBeam, a two-arc coplanar VMAT on the Varian TrueBeam (TB-VMAT), and a two-arc coplanar VMAT on the Varian Halcyon (HAL-VMAT). All treatment plans aimed to deliver 50.4 Gy in 28 fractions to the planning target volume (PTV) while minimizing dose to OARs. The planning process began by applying identical preset optimization templates for each plan, followed by iterative refinements of objectives and priorities to accommodate individual plan requirements. All plans were normalized to ensure that 100% of the prescription dose covered 95% of the PTV. Dosimetric evaluation included PTV metrics (D, D, D, and D), the Paddick Conformity Index (PCI), the International Commission on Radiation Units and Measurements Report 83 (ICRU-83) homogeneity index (HI), the gradient index (GI), and doses to OARs for each technique. Statistical significance was assessed using the Wilcoxon signed-rank test with a p-value threshold of < 0.05.

RESULTS

HA plans demonstrated superior dosimetric indices for PTV, as indicated by the highest D (50.24 ± 0.05 Gy) and the lowest D (53.20 ± 0.23 Gy), HI (0.04 ± 0.00), and GI (3.56 ± 0.58) values (p < 0.05). These results indicated superior target coverage and a more homogeneous dose distribution. Furthermore, HA plans achieved the lowest maximum dose values for the following OARs: lenses, hippocampi, contralateral optic nerve, and contralateral retina (p < 0.05), thereby optimally sparing these critical structures. No significant differences were observed across techniques regarding D, D, PCI, or maximum dose to the ipsilateral optic nerve, ipsilateral retina, and optic chiasm.

CONCLUSIONS

HA plans demonstrated superior dosimetric performance, ensuring adequate target coverage, reduced PTV hotspots, and better OAR protection compared to coplanar VMAT plans on the Varian TrueBeam and Halcyon. These advantages suggest that.

摘要

目的

本研究旨在评估视神经鞘膜瘤(ONSM)患者靶区和危及器官(OARs)的剂量学结果,将新型自动非共面容积调强弧形放疗(VMAT)技术HyperArc(HA)与其他两种先进的VMAT技术进行比较。

方法

9例ONSM患者使用三种放射治疗技术重新制定计划:在瓦里安TrueBeam直线加速器上采用四个预配置非共面部分弧的HA技术、在瓦里安TrueBeam直线加速器上的双弧共面VMAT技术(TB-VMAT)以及在瓦里安Halcyon直线加速器上的双弧共面VMAT技术(HAL-VMAT)。所有治疗计划旨在对计划靶体积(PTV)给予28次分割、总量50.4 Gy的照射,同时尽量减少对OARs的剂量。计划制定过程首先为每个计划应用相同的预设优化模板,然后根据个体计划要求对目标和优先级进行迭代优化。所有计划均进行归一化处理,以确保100%的处方剂量覆盖95%的PTV。剂量学评估包括PTV指标(D、D、D和D)、帕迪克适形指数(PCI)、国际辐射单位与测量委员会第83号报告(ICRU-83)均匀性指数(HI)、梯度指数(GI)以及每种技术对OARs的剂量。使用Wilcoxon符号秩检验评估统计学显著性,p值阈值<0.05。

结果

HA计划显示出PTV的剂量学指标更优,表现为最高的D(50.24±0.05 Gy)和最低的D(53.20±0.23 Gy)、HI(0.04±0.00)以及GI(3.56±0.58)值(p<0.05)。这些结果表明靶区覆盖更好且剂量分布更均匀。此外,HA计划在以下OARs中实现了最低的最大剂量值:晶状体、海马体(hippocampi)、对侧视神经和对侧视网膜(p<0.05),从而最佳地保护了这些关键结构。在D、D、PCI或同侧视神经、同侧视网膜和视交叉的最大剂量方面,各技术之间未观察到显著差异。

结论

与瓦里安TrueBeam直线加速器和Halcyon直线加速器上的共面VMAT计划相比,HA计划显示出更优的剂量学性能,确保了足够的靶区覆盖、减少了PTV热点并更好地保护了OARs。这些优势表明……

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7877/12245833/807cfac16eb2/fonc-15-1531918-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验